ISPOREurope is fast approaching, and the Quantify Research team is looking forward to meeting with our current and future collaborators as well as presenting a wide variety of research.
Quantify will have a large group of in-house experts with diverse experience and […]
Since 2020, Quantify Research has been a proud partner to the European Medicines Agency coordinated ENCePP (European NEtwork for Centers of Pharmacoepidemiology and Pharmacovigilance) initiative.
This network brings together expertise and resources in pharmacoepidemiology and pharmacovigilance across Europe with […]
Using 10 years of national surveillance data from four Nordic countries, Quantify Research in collaboration with Pfizer found that a substantial amount of vaccine-preventable invasive pneumococcal disease remains present in elderly populations, despite the inclusion of pneumococcal conjugate […]
That’s a possible conclusion to draw from Sweden’s HTA body The Dental and Pharmaceutical Benefits Agency, TLV‘s report published this week, on the topic of improving access to drugs for rare diseases.https://www.linkedin.com/company/tlv-the-dental-and-pharmaceutical-benefits-agency/
The pharmaceutical market has shifted in […]
Don’t miss it!
On October 4th and 5th, Quantify Research’s CEO Kirk Geale and Lead Analyst Alexander Rieem Dun will be instructing the ISPOR—The Professional Society for […]
The natural history of severe asthma is complex and poorly understood, and until recently we were unable to effectively predict the progression of the disease. To shed light on this important area, we are delighted to share our latest study […]
Extensive article today in the Swedish newspaper Dagens Nyheter on the increasing burden of fatty liver disease (NAFLD), including an interview with Associate Professor Hannes Hagström, co-creater of the HERALD liver data platform together with Quantify Researchs Emilie […]
Quantify Research recently joined regulators and industry in the EMA’s Multi-stakeholder workshop on Real World Data (RWD) quality and Real World Evidence (RWE) use.
???? ??????????? ??????? ?? ???? ??????????? ???? ???????. ????? ??????? ???? ???? ???:
⭐ […]
Studying rare diseases in real-world evidence often comes with challenges, such as lack of disease-specific diagnosis codes and complex definition of relevant endpoints. Over the years, Quantify has faced these challenges on […]
Denmark, through the Danish Medicines Council, will join FINOSE! We at Quantify foresee that this can potentially be a great preparation for both HTA bodies and pharmaceutical manufacturers for the upcoming EU HTA regulation. The addition of Denmark to FINOSE […]
